FILE - In this Dec. 21, 2012 file photo, an Indian activist from health groups holding placards as they participate in a protest against Swiss drug maker Novartis AG outside their office in Mumbai, India. The case - involving Novartis AG's cancer drug Glivec - pits aid groups that argue India plays a vital role as the pharmacy to the poor against drug companies that insist they need strong patents to make drug development profitable. A ruling by India’s Supreme Court is expected in early 2013. (AP Photo/Rajanish Kakade, File)